Friedman et al. call for expansion of interventions that do not only target overdose death rates but also social inequalities that place minoritised communities at the disadvantage in receiving care
Harm Reduction International publishes a summary of major debates, decisions and documents related to drug policy from the 55th session of the Human Rights Council.
TEDI find consistent adulteration and risk trends across Europe's drug market since 2018, and call for more resources to improve market monitoring and harm reduction.
Michaud et al. analyse public discourse surrounding safer supply, highlighting potential implications of moral panic for people who use drugs and healthcare access.
The EU Civil Society Forum on Drugs discusses decriminalisation, focusing on members' perspectives and noting how this framework could contribute to the EU's commitment to balanced, human-rights based approach.
EuroNPUD explore community-led communicable disease testing and care integration for people who use drugs, assessing best practice and attitudes surrounding these services.
IDPC and other organisations encourage the Special Rapporteurs to acknowledge the harmful effects of criminalising drug use and sex work in relation to the policing of people living in poverty in public spaces.
Youth RISE, SSDP International and Young Wave present a sustainability framework to develop skills, knowledge, network and strategies for young people in drug-related organisations internationally.
ICON reveals challenges faced by service users, including limited treatment options and discrimination, underscoring the need for improved support and a rights-based approach.
